Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 60 to 80 years old; 2. Previous diagnosis of atrial fibrillation and having an electrocardiogram of atrial fibrillation; 3. CHA2DS2-VASc score >=2 for men and >=3 for women; 4. Patients are willing to sign informed consent to participate in this study; 5. Patients can complete the study according to the study protocol.
Exclusion criteria
Exclusion criteria: 1. Do not meet the inclusion criteria; 2. Congenital heart disease, mental disease, dementia or neurological disorders; 3. Severe liver and kidney dysfunction; 4. Prosthetic valve replacement, or valve diseases that require surgical treatment within the last 3 years; 5. Atrial fibrillation with reversible cause (e.g. cardiac surgery, pulmonary embolism, untreated hyperthyroidism); 6. The expected survival time was less than 2 years; 7. The patients were accompanied with other diseases that need long-term anticoagulant therapy 8. Previous invasive treatment for atrial fibrillation (surgical or catheter-interventional, including maze surgery, catheter ablation, left atrial appendage occlusion, etc.); 9. Currently participating in clinical research of any experimental drug or device.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anticoagulant treatment rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of continious anticoagulant treatment;Initiation rate of anticoagulant treatment;All-Cause Mortality;Stroke rate;Incidence rate of transient ischemic attack;Incidence rate of systemic embolism;Incidence rate of massive haemorrhage; | — |
Countries
China
Contacts
Shanghai First People's Hospital